erythromycin ethylsuccinate has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhamou, JP; Funck-Brentano, C; Pessayre, D | 1 |
| Maria, VA; Victorino, RM | 1 |
1 review(s) available for erythromycin ethylsuccinate and Bile Duct Obstruction
| Article | Year |
|---|---|
[Hepatitis caused by various derivatives of erythromycin].
Topics: Autoantibodies; Chemical and Drug Induced Liver Injury; Cholestasis; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Humans; Liver; Liver Function Tests; Recurrence | 1983 |
1 other study(ies) available for erythromycin ethylsuccinate and Bile Duct Obstruction
| Article | Year |
|---|---|
Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis; Erythromycin; Erythromycin Ethylsuccinate; Humans; Indomethacin; Lymphocyte Activation; Male; Prostaglandins; T-Lymphocytes, Regulatory | 1985 |